Curtiss-Wright (CW) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
26 Mar, 2026Voting matters and shareholder proposals
Election of nine director nominees is up for shareholder vote at the annual meeting scheduled for May 7, 2026.
Ratification of Deloitte & Touche LLP as the independent registered public accounting firm for 2026 is proposed.
Advisory (non-binding) vote on the compensation of named executive officers is included.
Additional business may be addressed if properly brought before the meeting or any adjournment.
Board of directors and corporate governance
Director nominees for election include Lynn M. Bamford, Bruce D. Hoechner, Jeffrey J. Lyash, Glenda J. Minor, Anthony J. Moraco, William F. Moran, Robert J. Rivet, Peter C. Wallace, and Larry D. Wyche.
Executive compensation and say-on-pay
Shareholders are asked to cast a non-binding advisory vote to approve executive compensation for named officers.
Latest events from Curtiss-Wright
- Proxy covers director elections, auditor ratification, say-on-pay, and strong ESG and governance.CW
Proxy filing26 Mar 2026 - Record 2025 growth and strong 2026 outlook driven by margin expansion and robust demand.CW
Q4 202512 Feb 2026 - Strong growth, margin expansion, and new mandates drive momentum across defense, aerospace, and nuclear.CW
18th Annual Global Transportation & Industrials Conference3 Feb 2026 - Q2 sales up 11%, adjusted EPS up 24%, record backlog, and 2024 guidance raised.CW
Q2 20242 Feb 2026 - Poised for rapid growth, especially in commercial nuclear and SMRs, through innovation and strategic acquisitions.CW
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - Margin expansion, innovation, and nuclear growth position the business for long-term value creation.CW
Stifel 2024 Cross Sector Insight Conference31 Jan 2026 - Pivot to Growth strategy drives strong revenue, margin expansion, and future-ready investments.CW
Jefferies Global Industrial Conference 202422 Jan 2026 - New three-year targets leverage R&D, nuclear growth, and defense alignment for sustained expansion.CW
Morgan Stanley 12th Annual Laguna Conference20 Jan 2026 - Q3 2024 delivered 10% sales growth, record backlog, and higher full-year guidance.CW
Q3 202417 Jan 2026